This interaction often leads to the deposition of osteolytic factors such as RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand), which promotes osteoclast-mediated bone resorption, creating a supportive niche for tumor growth. Here, TNFSF11 is linked to neoplasm.